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Tailoring of alginate–gelatin microspheres properties for oral
Ciprofloxacin-controlled release against Pseudomonas aeruginosa
German A. Islan and Guillermo Raul Castro
Nanobiomaterials Laboratory, Institute of Applied Biotechnology (CINDEFI, UNLP-CONICET CCT La Plata) – Department of Chemistry, School of
Sciences, Universidad Nacional de La Plata, La Plata, Argentina
Abstract
Context: Ciprofloxacin (Cip) is a broad spectrum antibiotic frequently used in the treatment
of infectious diseases caused by Pseudomonas aeruginosa. Cip oral administration is commonly
associated with poor drug biodisponibility, gastrointestinal tract irritation, and toxic undesir-
able side effects.
Objective: The aim of this work is to provide an oral biopolymeric system for controlled release
of Cip.
Materials and methods: Alginate–gelatin blend microspheres were crosslinked in the presence
of 1,2-propylene glycol, calcium, and glutaraldehyde. Studies of Cip encapsulation and release
were performed. Matrix characteristics were studied simultaneously by optical microscopy
and Fourier transform infrared spectroscopy (FTIR) using synchrotron light, and by
texturometric analysis. Microsphere surface topologies were observed by scanning electron
microscopy (SEM), atomic force microscopy (AFM), and epifluorescence microscopy.
Results: Microspheres crosslinked with glutaraldehyde showed about 80% Cip encapsulation
and less than 10% Cip release under simulated gastric conditions in 15min, while a controlled
release profile was observed at intestinal environment conditions. Antimicrobial activity against
P. aeruginosa showed an increasing bacterial growth inhibition in time. Finally, bovine serum
albumin (BSA) was used as model protein for binding of macromolecules onto active surface
of microspheres, with a consequently modulation of Cip release.
Discussion and conclusions: The results are indicating that alginate/gelatin matrix crosslinked
via Ca2þ and glutaraldehyde can be tailored by decorating the microsphere surface with
biological active molecules useful for targeting, making a potential tool to improve Cip oral
administration for infection diseases.
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Introduction
Ciprofloxacin (Cip) is a fluoroquinolone with broad anti-
microbial spectrum, clinically indicated for the treatment of
bacterial diseases such as acute uncomplicated cystitis in
females, chronic bacterial prostatitis, urinary and lower
respiratory tract infections, acute sinusitis and skin-related
infections, bone and joint infections, infectious diarrhea,
typhoid fever and uncomplicated cervical and urethra gonor-
rhea (Appelbaum & Hunter, 2000). Also, it is commonly
administered in cystic fibrosis as a control agent against
opportunistic Pseudomonas aeruginosa (Wood & Ramsey,
1996). The Cip antimicrobial activity is meanly based on the
inhibition of DNA gyrase, enzyme necessary to separate
bacterial DNA and in consequence inhibiting cell division.
However, orally administered Cip is commonly associated
to gastric and intestinal problems (Norrby, 1991). Besides,
Cip molecules have tendency to stack themselves which is
associated to a reduction of biodisponibility and low aque-
ous solubility under physiological condition (Turel, 2002;
Fernandez-Teruel et al., 2013). Additionally, the harsh
environmental stomach condition and the antibiotic residence
time are points to be considered for Cip inactivation. All these
reasons are converging for the development of an effective
encapsulation system for Cip oral delivery.
Alginates are linear anionic polysaccharides composed of
b-manuronic acid (M units) and a-guluronic acid (G units)
linked by 1–4 bounds. Alginates are non-toxic, no immuno-
genic, biocompatible, and their gelation proceeds by cross-
linking with divalent ions forming ‘‘egg box junctions’’.
Calcium is the preferred biocompatible crosslinker cation
for biomedical applications of alginate gels (Rehm, 2009).
The alginate crosslinking is made by ionotropic interaction
between calcium ions and the free carboxyl groups of
guluronic acid residues (pKa& 3.0) of two neighboring
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alginate chains, resulting in the formation of stable three-
dimensional network (Velings & Mestdagh, 1995).
Gelatin is a natural polymer obtained by a controlled
hydrolysis of the fibrous insoluble collagen, protein widely
found in the nature. Collagen is the major constituent of skin,
bones, and connective tissue. Its biodegradability and bio-
compatibility properties makes gelatin appropriate in medical
industry as plasma expander, wound dressing, adhesive,
absorbent pad, and for drug delivery (Kuijpers et al., 2000).
Gelatin is the denatured form of collagen with aspartic
(0.50 mmol/g, pKa¼ 4.0–4.5) and glutamic (0.78 mmol/g,
pKa¼ 4.5) as major anionic groups and lysine (0.30 mmol/g,
pKa¼ 10.0–10.4) and arginine (0.53 mmol/g, pKa412) as the
major cationic side groups. Gelatin type B has an isoelectric
point of 4.9, and its pKa values are pKa1¼ 3.6 and pKa2¼ 7.8.
At pH below 5.0, it is positively charged and can make
coacervates with negatively charged molecules (e.g. DNA)
(Rose, 1990).
Some previous studies have focused on the use of alginate
and gelatin coacervates, due the blend advantageous proper-
ties for the development of drug release matrices (Klak et al.,
2013). Alginate–gelatin films encapsulating Cip were devel-
oped for local treatment of infections and for wound dressing
(Dong et al., 2006; Saarai et al., 2013). Also, alginate–gelatin
tablets were used for controlled release of diltiazem hydro-
chloride and endosulfan (Tapia et al., 2007; Roy et al., 2009).
However, uncoated gelatin capsules containing proteins as
cargo disintegrated in the stomach within 15 min of ingestion
in human volunteers. Instead, gelatin capsules coated with
20% alginate cross-linked with calcium chloride, remained
intact in the stomach and then migrated to the ileocecal
region of the intestine and then disintegrated (Narayani &
Rao, 1996).
Previous works on drug formulations were focused on
chemical crosslinking of either alginate or gelatin with
calcium ions for alginates, or formaldehyde, glutaraldehyde,
epoxy compounds, and carbodiimides for gelatin. Among
these agents, glutaraldehyde is widely used crosslinking agent
that reacts with gelatin free non-protonated "-amino groups
(–NH2) of lysine or hydroxylysine through a nucleophilic
addition-type reaction (Chan & Heng, 2002).
The aim of the present work was to develop and study an
alginate–gelatin matrix for Cip encapsulation in the presence
of 1,2-propylene glycol and by double crosslinking via
calcium ions for alginate and glutaraldehyde for gelatin.
Also, the interaction of macromolecules, using BSA as model,
onto matrix active surface was analyzed. Matrix character-
ization was performed by IR synchrotron beamline, texturo-
metric parameters, scanning electron (SEM), atomic force
(AFM), and epifluorescence microscopies. Cip release from
the matrices was analyzed by kinetic studies of antimicrobial
activity against P. aeruginosa.
Materials and methods
Cip (1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazi-
nyl)-3-quinoline carboxylic acid) and BSA were purchased
from Sigma-Aldrich (Buenos Aires, Argentina). Sodium
Alginate was donated by Monsanto (Buenos Aires,
Argentina). Gelatin type B (MW¼ 125, food grade) was
kindly provided by Kraft (Buenos Aires, Argentina). 1,2-
Propylene glycol (¼ 1.036 g/cm3) was purchased from
Anedra (Buenos Aires, Argentina). BSA Alexa fluor 488
conjugate (BSA*) was purchased from Molecular Probes
(Invitrogen, Eugene, OR). P. aeruginosa ATCC 15442 was
used in the experiments. Other reagents and solvents were
of analytical grade, and used as received.
Determination of Cip and Biopolymers Interactions
Interaction of Cip with alginate and alginate/gelatin solution
blends was studied at different pHs. Alginate and alginate/
gelatin (2:1) solutions were prepared by dissolving the
weighted powders in buffers at pH 4.0–5.0 (50 mM acetate
buffer), 6.3, 6.8, 7.4 (25 mM phosphate buffer), and 9.0
(25 mM borate buffer) previously prepared in distilled water.
Four hundred ten microliters of the polymer blends were
mixed with 90 ml of Cip solution (100 mg/ml) and stirred for
one hour at room temperature. Later, the biopolymer complex
was precipitated by the addition of 1.0 ml of cold ethanol
(96.0%) (Islan et al., 2012). The resulting suspension was
centrifuged at 10 000 g for 10 min. The remaining Cip in the
supernatant was determined spectrophotometrically at 280 nm
(Beckman DU640, Euclid, OH) using appropriate calibration
curve.
Crosslinking of alginate/gelatin microspheres
containing Cip
A Cip solution (36.0 mg/ml) was mixed with alginate–gelatin
(2.0–1.0%, w/v) and pH adjusted to 4.0 (50 mM acetate buffer).
Microspheres were prepared by dropping the Cip–biopolymer
solution into 500 mM CaCl2 dissolved in 1,2-propylene glycol–
water (1:1 v/v), which was demonstrated to increase the Cip
incorporation on biopolymeric matrices (Islan et al., 2013).
The solution was gently stirred in an ice cooled bath for 20 min.
Later, the microspheres were filtrated and washed twice with
sodium bisulfite aqueous solution, followed by air dried for
10 min and stored at 5 C until use. In the case of alginate/
gelatin microspheres crosslinked by glutaraldehyde, the
reagent was added to the calcium solution at 2.5% (w/v) final
concentration, in order to produce gelatin crosslinking.
After synthesis, microsphere size distributions of wet
and dried samples were determined by optical microscopy.
The average diameter was determined in 100 microspheres of
each sample randomly selected.
Measurement of Cip encapsulation in alginate–gelatin
microspheres
Cip was determined in solution before and after biopolymer
gelation followed by filtration. The difference between
total and residual Cip was considered as the encapsulated
antibiotic.
Synchrotron light analysis
Freeze-dried biopolymer samples were cut and put into the
analysis chamber of SMIS infrared beamline (Soleil, French
National Synchrotron Facility, Saint-Aubin, France). Analyses
of samples were simultaneously performed by optical micros-
copy and Fourier transform infrared spectroscopy (FTIR).
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SEM
Sample analysis by SEM was carried out using freeze-dried
microspheres. The samples were prepared by sputtering the
surface with gold using a Balzers SCD 030 metalizer (Blazers
Co., Saskatchewan, Canada) obtaining a layer thickness of
between 15 and 20 nm. Microsphere surfaces and morpholo-
gies were observed using Philips SEM 505 model (Rochester,
NY), and processed by an image digitalizer program (Soft
Imaging System ADDA II (SIS), Lakewood, CO).
SEM images were analyzed by Image J software (NIH,
Madison, WI). The roughness of the surface was reflected
by the standard deviation of the gray values of all the pixels
on the image. First, image files were opened by the software
and converted to an 8-bit image. Then all the pixels on the
image were selected and statistically measured by a computer
equipped with the software. The surface smoothness is
proportional to the inverse of the sample standard deviation.
AFM
All images were obtained in ambient conditions using a
Multimode-Nanoscope V (Veeco, Santa Barbara, CA) operat-
ing in tapping mode with an etched silicon Probe model Arrow-
NCR-50 Nano World (cantilever resonance frequency:
258 kHz, force constant 42 N/m; tip radius 5–10 nm). Typical
scan rates were in the range of 1.0–1.5 Hz. AFM samples were
prepared by using a piece of glass (1 cm 1 cm) immersed into
alginate–gelatin (2:1) solution. Later, the glass was wringed
and immersed into a solution containing 500 mM CaCl2 in
1,2-propylene glycol–water (1:1) without (a) or with (b)
glutaraldehyde (2.5%, w/v). The glasses were freeze dried and
later observed by AFM. Images were analyzed by Nanoscope
7.30 software (Veeco, Santa Barbara, CA).
Measurement of texturometric parameters
Microspheres texture was analyzed in a TAXT 2i Texture
Analyzer (Stable Micro Systems Ltd, Godalming, UK)
equipped with a load cell of 25 kg and a cylindrical metal
compression plate of 75 mm diameter (p75). The texture
profile analysis (TPA) consisted in two compression cycles
at 0.6 mms1 to 30% of the original microspheres height.
In each assay, three microspheres were simultaneously
compressed. Data were processed with the Texture Expert
(Texture Expert, Hamilton, MA) software and the textural
parameters (hardness and cohesiveness) were calculated from
the TPA curve of force (N) versus time (s) with the following
definitions (Bourne & Comstock, 1981): Hardness (N) is
defined as the peak force during the first compression cycle;
cohesiveness (dimensionless) as the ratio of the areas under
the second and first compression (A2/A1). The results
represent the average means of at least triplicate tests.
Comparison between alginate/gelatin microspheres
treated and untreated with glutaraldehyde was performed.
Stability of both matrices was determined by incubation of
20 microspheres at pH 1.2 (50 mM Clark and Lubs buffer)
and pH 7.4 (40 mM phosphate buffer) at 37 C for two
hours. Microspheres were filtered and washed, later the
hardness and cohesiveness were measured as previously
described.
Kinetic release of Cip from alginate microspheres
Wet microspheres (200 mg) were suspended in aqueous
buffers on rotary shaker at 10 pm and 37 C. Cip kinetic
release in vitro were performed under gastric conditions in
50 mM KCl/HCl buffer (pH¼ 1.2) and at simulate intestinal
environment in 40 mM phosphate buffer solution (pH¼ 7.4).
At defined time intervals, 1.0 ml samples were taken off
and the absorbance was measured at the maximum wave-
length of Cip in each buffer (277 and 270 nm at pH¼ 1.2 and
7.4, respectively). Fresh media (1.0 ml) were added to keep a
constant volume.
Antimicrobial activity of Cip formulation against
P. aeruginosa
The disc diffusion method (DDM) was modified by using
microspheres containing Cip. Alginate–gelatin microspheres
with and without glutaraldehyde crosslinking procedure were
tested against P. aeruginosa using modified DDM according
to the National Committee for Clinical Laboratory Standards
(NCCLS, Wayne, PA) Briefly, 4–5 colonies of the micro-
organism were taken and resuspended in sterile physiological
solution (154 mM NaCl) and the turbidity of the culture
was adjusted to 0.5 McFarland scale (McFarland, 1907). Petri
dishes containing 25 ml of Mueller–Hinton agar were
inoculated using sterile cotton swab dipped in the inoculum
suspension. Later, microspheres were placed on the surface of
the inoculated agar plates and incubated at 37 C. Cip release
kinetic was followed by removing one microsphere at each
time (20, 40, 60, 90, 120, and 180 min). Finally, plates were
left in incubation for 24 h. Then, inhibition zones were
determined and measured to the nearest whole millimeter
from the back of the inverted Petri dishes using sliding
calipers. The assays were performed in duplicate.
Coating of microspheres with BSA
BSA as a model protein was used to test the binding onto
surface of alginate/gelatin microspheres previously activated
by the glutaraldehyde treatment. Briefly, microspheres
synthesized in the presence of 1,2-propylene glycol and
glutaraldehyde were filtered, washed, and placed in contact
with a cold solution of BSA (10.0 mg/ml) at pH¼ 4.0 for
10 min. Later, the microspheres were washed and stored at
5 C. Effect on surface was analyzed by SEM images and also,
the effect on Cip release was evaluated.
To confirm BSA binding to microspheres and discard
possible changes on surface by degradation, the previous
protocol was repeated by using BSA Alexa fluor 488
conjugate. Glutaraldehyde-treated and -untreated micro-
spheres were observed at Leica DM 2500 (Leica
Microsystems, Buffalo Grove, IL) epifluorescence micro-
scope at visible and fluorescence mode with a blue excitation
filter (450–490 nm).
Finally, BSA quantification was performed to determine
the protein/microsphere mass ratios. Briefly, 50 mg of
microspheres were incubated in the presence of 1.0–
10.0 mg/ml cold BSA solutions at pH¼ 4.0 for 10 min.
After incubation, microspheres were filtrated. The remnant
BSA in the filtered solution was assayed by UV absorption at
DOI: 10.3109/10717544.2013.870257 Oral Ciprofloxacin-controlled release against P. aeruginosa 617
280 nm with proper calibration curve. Difference between the
initial and the remainder BSA in the filtered was considered
as the amount of adsorbed BSA on surface microspheres.
Considering the absorbance measured and correlating it
with a BSA calibration curve, concentration was determined
and compare to the initial BSA concentration, in order to
calculate the amount of bound BSA to microsphere.
Statistical analysis
All experiments were carried out with at least by two
independent experiments run each one by duplicate.
Comparisons of mean values were performed by the one
way analysis of variance (ANOVA) with a significance level
of 5.0% (p50.05) followed by Fisher’s least significant
difference test at a p50.05.
Results
Cip interactions with alginate and alginate–gelatin
coacervate
Interaction between Cip and alginate strongly depends on pH
(Figure 1). The binding of Cip with alginate increases when
the pH decreases. On one hand, the electrostatic interactions
of negative charged alginate with the cationic Cip reached a
maximum in the range of pH 4.0–5.0. Below pH 3.5, the
alginate solution becomes unstable and precipitates as alginic
acid (data not shown). On the other hand, the interaction
of Cip and alginate decreased because the pKa of Cip
carboxylate is 6.1 and the piperazinyl group at C-7 is 8.2
at pHs close to 6.0 or higher (Islan et al., 2012).
Incorporation of type B gelatin into the alginate solution
increased up to 80% the Cip interaction with the polymer blend
at pH¼ 4.0 (Figure 1). The pKas of alginate are between
3.4 and 3.7 and for Cip is 6.1, both are far away from the
pH 4.0–5.0, in consequence the ionization states of these
molecules do not changed and consequently the increase of Cip
uptake by the blend that can be attributed only to the presence
of B-gelatin, but not by its interaction with alginate. The
positive interaction of Cip with B-gelatin at pH 4.0 can be
justified by the presence of high levels of aspartic and glutamic
acid residues on gelatin with close pKas to 4.0 (Rose, 1990).
The decrease of Cip binding to alginate–gelatin blend
with the increase of pH could be explained mainly by the
changes of polymer surface density charges of B-gelatin
reaching the Iso Electric Point (IEP), between 4.6 and 5.2
approximately as previously reported (Harrington & Morris,
2009). When the pH of B-gelatin is reaching the IEP, the
associative interaction between alginate and gelatin becomes
weaker, and has a tendency to be repulsive with phase
separation (Antonov et al., 1996). The process is considered
as segregative interaction between both polymers by increas-
ing the order in the protein going from extended coil to helix,
a more ordered form, triple helix in the case of B-gelatin
(Gilsenan et al., 2003). In such case, the amount of B-gelatin
ionic residues available for Cip binding was drastically
reduced. Also, the increase of pH over the IEP generates
the zwiterionic form of B-gelatin increasing the strength
of the triple helix configuration (Wu¨stneck et al., 1988).
In addition, the positive-charged Cip molecule at acid pH
becomes neutral (or zwiterionic) close to pH 7.4, and
consequently the ionic interaction with the anionic polymer
blend is reduced.
Evaluation of alginate–gelatin homogeneity in the
matrix by FTIR synchrotron analysis
Matrices were analyzed simultaneously by optical micros-
copy and FTIR synchrotron light (SMIS beamline, Soleil
Synchrotron, Saint-Aubin, France). Alginate matrix showed
two characteristics peaks attributed to the asymmetric and
symmetric stretching vibration modes of R-COO group, at
1627 cm1 and 1409 cm1, respectively (Figure 2, left).
Also, the results are confirming our previous determinations
using bench FTIR spectrometer (data not shown), but taking
advantage of the high synchrotron sensitivity to small band
changes produced by the micro-environment. These results
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Figure 1. Binding of Ciprofloxacin to 2.0% alginate (g) and alginate–gelatin 2:1 blend (œ) at different pHs.
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are indicating no effect on alginate gel structure by the
presence of 1,2-propylene glycol (50%, v/v) during the ionic
gelation process. Similar results of alginate/gelatin matrix
gelled in aqueous media using bench FTIR spectrometer were
previously reported (Dong et al., 2006).
Characteristic gelatin IR peaks at 1653 cm1, 1546 cm1,
and 1236 cm1 were attributed to the bands of: amides,
produced by the C¼O and C–N stretching vibrational modes,
and N–H bending modes. The stretching vibration of O–H
bonded to N–H produced a wide absorption band around
3421 cm1. FTIR spectra alginate–gelatin matrix showed the
characteristic absorption bands at 1653 cm1 and 1546 cm1
of gelatin shifted to lower wavenumbers to 1642 cm1 and
1535 cm1 respectively (Figure 2, right). Similarly, the
absorption band around 3421 cm1 shifted to a lower
wavenumber at 3411 cm1, suggesting an increase in the
hydrogen bonding interaction. These results strongly evidence
the intermolecular interactions and compatibility between
alginate and gelatin described previously (Dong et al., 2006).
Besides the high sensitivity of IR synchrotron beamline, the
Cip characteristic IR bands were not elucidated because
of low antibiotic concentration present in the formulation.
However, as Cip molecules tend to stack themselves
producing crystals of 5 mm in size clearly observed by optical
microscopy (data not shown) and they probably interfere
with FTIR detection, there was evidence that no aggregation
of Cip molecules was produced during gel formation.
The presence of biopolymers may stabilize Cip molecules.
Microsphere size distribution
Alginate/gelatin and alginate/gelatin/glutaraldehyde micro-
sphere sizes were evaluated by optical microscopy.
Spherical microspheres around 900 mm with a narrow size
distribution were obtained for both types of matrices in wet
state. However, after dehydration (air or freeze dried), the size
was reduced to 500 mm, but keeping their morphology, narrow
size distribution, and hydrogel properties.
SEM images
The external structure of alginate microspheres synthesized
in 1,2-propylene glycol–water (1:1) was improved compared
to the aqueous ionic gelation synthesis by the lack of
surface cracks and big pores, as previously reported (Islan
et al., 2013).
Gelatin incorporation to the alginate matrix and crosslinked
only in the presence of calcium ion showed a homogeneous
distribution of microspheres with spherical shapes (Figure 3,
top), suggesting good compatibility between both biopolymers
as previously observed by FTIR synchrotron light. However,
the surface morphology of the blended microspheres seems to
be more granulated compared to alginate-based matrix.
Differences were essentially attributed to the presence of
small valleys probably composed of non-crosslinked gelatin on
microsphere surface. The microsphere crosslinked in the
presence of both calcium ion and glutaraldehyde offers an
alternative to produce a double crosslinked matrix in order to
Figure 2. Characterization of alginate and alginate/gelatin matrices by simultaneous optical microscopy and FTIR using SMIS synchrotron light.
Left: alginate. Right: alginate/gelatin. Top: optical microscopy of a portion of matrix. Below: 3D-FTIR spectra of red line in the optical
microscopy images.
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get more tight surface structure. Alginate–gelatin micro-
spheres treated with glutaraldehyde showed smoother surface
compared to the previous ones (Figure 3, below).
SEM microscopy of microspheres is suggesting a thin
layer coating over the surface made by glutaraldehyde. Also,
microparticle sphericity was kept when a double crosslinking
procedure was performed. Images analyzed by Image J
software produce a standard deviation of 52 and 35 for
blended and glutaraldehyde blended-treated microspheres,
respectively, suggesting that the double crosslinking tech-
nique increases the smoothness of microspheres and conse-
quently reducing the surface pores concomitantly with Cip
diffusion to outside the microspheres. Changes in micro-
spheres surface in both conditions confirm the results
observed under naked eyes.
AFM studies
AFM studies of the biopolimeric blend showed the effect
of glutaraldehyde and confirmed the SEM results. Alginate/
gelatin microspheres showed homogeneously distributed
aggregates on the whole surface, mainly composed of non-
crosslinked gelatin chains. Treatment with this crosslinking
agent directly affect microsphere surface, by reordering the
biopolimeric chain of alginate and gelatin and generating a
smother surface (Figure 4). Analysis of AFM glutaraldehyde-
treated alginate/gelatin matrix images using Nanoscope 7.30
software evidenced the reduction of surface aggregates
(10 nm of height, and less than 500 nm of diameter) and
displayed strong differences in the surface profile roughness
compared to the untreated matrix.
The relevance of smoothness evaluation is related to the
capability of glutaraldehyde to decrease matrix porosity and
homogenize microsphere surface, tailoring the matrix proper-
ties. This parameter probably has a direct impact on release
profile of the encapsulated molecules, as the porosity
reduction represents a physical barrier to control the delivery
of biological active molecules.
Texturometric assay
Hardness and cohesiveness of microspheres were evaluated.
However, no significant hardness differences were found
(p40.05) between alginate/gelatin glutaraldehyde-treated
and -untreated microspheres (2.19 0.26 and 2.36 0.35,
respectively), indicating that the resistance of the gel matrix
to compression is quite similar in both matrices (Table 1).
Cohesiveness analysis of samples also gave similar results of
Figure 3. SEM images: top: alginate/gelatin matrix; below: alginate/gelatin matrix crosslinked in the presence of glutaraldehyde.
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0.45 0.02 and 0.44 0.02 for treated and untreated matri-
ces. The cohesiveness results of both matrices are indicating
the same degree of difficulty in breaking down the gel’s
internal structure. Hardness and cohesiveness results are
strongly suggesting that glutaraldehyde treatment on the
alginate/gelatin matrix mainly produces surface changes
without modifying the internal gel structure of the
microspheres.
In addition, stability of both matrices was tested in
simulated physiological fluids. Alginate/gelatin and glutar-
aldehyde-crosslinked alginate/gelatin microspheres showed
the same texturometric parameters incubated at simulated
gastric pH (1.2) for two hours. No significant differences
in hardness and cohesiveness (p40.05) were found, but a
decrease of around 25% and 10% respectively was observed
in comparison with non-incubated microspheres (Table 1).
The fact can be attributed mainly because of the extreme
acid pH which probably affects the ionization degree of the
crosslinked matrix.
However, significant differences in hardness and cohe-
siveness (p50.05) between both types of microspheres
incubated at pH 7.4 (simulated intestinal media) for two
hours were observed. On one hand, alginate/gelatin micro-
spheres crosslinked only by calcium ion were completely
destabilized after incubation at pH 7.4 and the values of
hardness and cohesiveness were below the low detection limit
of the technique. On the other hand, microspheres double
crosslinked with both agents (calcium ion and glutaraldehyde)
showed a higher stability to the single crosslink method
(Caþ2), preserving 35% of their initial hardness and almost
the 50% of the cohesiveness. The results suggest an increase
in matrix stability by glutaraldehyde crosslinking, mainly due
to a coating surface layer that reduces microsphere erosion.
Cip encapsulation
Cip encapsulation was evaluated in alginate-based micro-
spheres produced by ionic gelation in the presence of calcium
ion. The encapsulation percentage was increased around two
times when 1,2-propylene glycol was in the synthesis medium
(Table 2). However, when 1.0% (w/v) gelatin was incorpo-
rated to the alginate (2:1 ratio) a significant decrease of about
20% of Cip encapsulation was observed (p50.05). The result
could be explained considering the isoelectric point of gelatin
as follow: at the encapsulation pH of 4.0, the Cip and also
the gelatin molecules were positive charged, competing for
the negative charged sites of alginate. As gelatin molecule
possesses higher MW than Cip molecule, it has more available
binding sites to interact with alginate negative charge chains,
excluding Cip from the matrix. However, when surface
treatments were carried out in the presence of 50% (v/v)
Figure 4. AFM images of alginate/gelatin matrix untreated (left) and treated with glutaraldehyde (right). The corresponding roughness profiles
analyzed by Nanoscope 7.30 software are shown.
Table 1. Determination of microspheres stability by texturometric assay
without and with glutaraldehyde crosslinking at gastric (1.2) and
intestinal (7.4) pHs incubated at 37 C for two hours.
Alginate–gelatin
Alginate–gelatin/
glutaraldehyde
pH Hardness Cohesiveness Hardness Cohesiveness
Before incubation 2.36 0.35 0.44 0.02 2.19 0.26 0.45 0.02
1.2 1.77 0.14 0.40 0.01 1.81 0.10 0.42 0.02
7.4 ND ND 0.72 0.05 0.21 0.14
ND, not determined (values below the limit detection of the technique).
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1,2-propylene glycol, a rise of at least two times in Cip
encapsulation was observed in all cases. Addition of 1,2-
propylene glycol in the gelling solution at 0 C increases the
viscosity in about 12 times related to water, which made
a drastic reduction of Cip diffusion from the microsphere
to the bulk (Curme & Johnston, 1952; Islan et al., 2013).
Additionally, the Cip encapsulation increased 6% when blend
matrix was double crosslinked with calcium and glutaralde-
hyde under the same experimental conditions.
Release of Cip
A Cip burst release close to 75% was observed when alginate
base microspheres were incubated under simulated stomach
conditions at pH¼ 1.2 and 37 C for 30 min (Figure 5).
A reduction in almost two times of Cip release from the
microspheres was found when alginate was blend with 1.0%
(w/v) gelatin. The plots had similar biphasic Cip release
profiles: fast burst release accounting for 83 and 56% for
alginate and alginate–gelatin blend microspheres, respect-
ively, in the first hour. This fact can be attributed to the
dissolution of the Cip placed on microsphere surface or those
molecules partially embedded just below the surface. The
pseudo-plateau phase showing little subsequent Cip release
(less than 10%) during the following hours because of the
drug more deeply entrapped inside in the matrix. This is a
common phenomenon for most matrices in drug delivery
systems described as the ‘‘channel effect’’ (Huang & Brazel,
2001). Besides, alginate–gelatin microspheres treated with
glutaraldehyde released only 25% of the initial drug concen-
tration after 30 min of incubation under the same simulated
conditions as mentioned before. Considering that the expected
residence time of microspheres into stomach fluids is less
than 30 min (for a fasting patient with empty stomach), more
than 75% of the Cip will be available at intestine when Cip is
dosed encapsulated into microspheres, avoiding potential
stomach irritation. The reduction in the cumulative drug
release was suggesting the presence of an additional barrier,
e.g. a thin layer, generated by glutaraldehyde crosslinking
of the biopolymers on the microspheres surface which reduces
the porosity of the matrix and consequently the amount of Cip
released to the medium. The blended microspheres showed a
Cip released profile which best fits fourth grade polynomial
equation (r2¼ 0.99). Meanwhile glutaraldehyde-treated blend
microspheres showed a linear relationship with r2¼ 0.94.
In both cases, the Cip release could be associated with the
diffusional mechanism of the drug from the matrix to the bulk
solution.
The Cip release from microspheres under simulated
intestinal media (pH¼ 7.4) was tested to determined if
microspheres are capable of release all the encapsulated
antibiotic (Figure 6). Alginate-based beads showed a high
Figure 5. Ciprofloxacin release from gel
microspheres composed of 2.0% alginate
(), 2.0% alginate– 1.0% gelatin (*) and
2.0% alginate–1.0% gelatin crosslinked with
glutaraldehyde (H) at pH¼ 1.2.
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Table 2. Encapsulation of Ciprofloxacin in different matrices and crosslinking conditions.
Synthesis media
Matrix Biopolymer (w/v, %) Calcium ion Glutaraldehyde 1,2-PGa Encapsulation (%)
Alginate–gelatin 2.0 þ   44 3
þ  þ 96 4
Alginate–gelatin 2.0–1.0 þ   33 5
þ  þ 77 3
þ þ þ 83 2
a1,2-PG, 1,2 propylene glycol.
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release rate, reaching 100% release in 90 min. Alginate–
gelatin microspheres decreased the antibiotic release in 20%
compared to the alginate microspheres. These results were in
agreement with the results obtained for Cip interaction
with the matrices previous mentioned (Figure 1). However,
the 100% of Cip was released in two hours, mainly produced
by completely matrix erosion as it was observed in stability
experiments (Table 1) and a non-desirable Cip retention
time inside the microspheres was observed. Besides, when
the blend microspheres were treated with glutaraldehyde,
a decrease in the release profile was found, due to the
presence of a thin compacted surface layer that was more
resistant to be eroded by the phosphate ions (Ca-quelating
compound) and pH. This procedure is providing more
stability to the matrix and the encapsulated Cip showed a
low release rate to the surrounded medium.
Antimicrobial activity of Cip
Efficacy of Cip released from the microspheres was tested
against P. aeruginosa (Figure 7). When microspheres were
placed in contact with the inoculated agar medium at different
times, an increased in the inhibition halo was found. The
results are in agreement to the kinetic of Cip release
from the blend microspheres performed in liquid medium.
Glutaraldehyde-treated Cip containing microspheres showed
a microbial inhibition increasing in time, reaching a halo
diameter higher than not treated blended microspheres.
This effect can be attributed to the higher Cip loading in
glutaraldehyde-treated microspheres compared to non-treated
microspheres (Table 2). Also, this result is confirming
the presence of an additional diffusional barrier made by
the glutaraldehyde crosslinking in the microsphere surface.
Figure 6. Ciprofloxacin release from gel
microspheres composed of 2.0% alginate
(), 2.0% alginate–1.0% gelatin (*) and 2.0%
alginate–1.0% gelatin crosslinked with
glutaraldehyde (H) at pH¼ 7.40.
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Figure 7. Antimicrobial activity of
Ciprofloxacin loaded into microspheres of
alginate–gelatin (g) and alginate–gelatin
crosslinked with glutaraldheyde (œ) against
Pseudomonass aeruginosa.
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The microbial inhibition diameter against P. aeruginosa
was 12.8 0.1 cm and 14.8 1.1 cm for the glutaraldehyde-
untreated and -treated blend microspheres, respectively. These
values were considered the 100% of inhibition in Figure 7.
These results confirm that the Cip released from these
biopolymeric matrices was biological active and produced
the growth inhibition of the tested microorganism. Besides,
the Cip was sustainably released from microspheres as the
inhibition halo was growing in time and glutaraldehyde-
treated microspheres released the antibiotic in a more
controlled profile. The results were in concordance with the
previously ones observed in simulated physiological fluids.
Binding of protein (BSA as model) onto active surface
of microspheres
The capacity of glutaraldehyde-activated microspheres to
bind proteins onto surface was evaluated using BSA as model
protein (Figure 8). Kinetic release profile of Cip was followed
under acid and alkaline conditions (Figure 8a and b).
The kinetic of Cip release is suggesting the presence of a
diffusional barrier for the antibiotic produced by the presence
of the BSA on surface. The Cip release profile from BSA-
coated microspheres under acid simulated gastric conditions
is showing a decrease of the drug release of roughly 20% in
60 min compared with non-coated BSA microspheres. After
about 60 min, the Cip release from both types of microspheres
trend to converge, which are suggesting a major role of BSA
coating on Cip release. In the case of Cip release kinetic
under slight alkaline intestine conditions, the drug release was
delayed 30% in two hours. Analysis of microspheres by SEM
is confirming the changes on microspheres surface by the
presence of aggregates made by the BSA that looks like
covered by knots (Figure 8c and d). In addition, epifluores-
cence microscopy to confirm BSA binding to microspheres
surface was carried out. First, alginate/gelatin microspheres
(glutaraldehyde treated and untreated) were immersed in
10 mg/ml of fluorescent BSA* (Alexa fluor conjugated), and
then filtrated and washed. The resulting microspheres were
observed by optical/fluorescence microscopy. Meanwhile
untreated microspheres did not show fluorescence (Figure 9,
top), glutaraldehyde-treated microspheres showed a high
green fluorescence intensity, using filters to excite the
BSA* around 497 nm (Figure 9, below). These pictures
are in concordance with the SEM images, confirming BSA
binding to microsphere surface and discarding possible
microsphere degradation after BSA incubation.
Finally, quantification of BSA attached to microsphere
surface was performed to obtain the protein/microsphere mass
ratios and established their properties as a tool for targeting
of biological molecules. When glutaraldehyde-treated micro-
spheres were incubated in 1.0–10.0 mg/ml cold BSA solutions
(at pH¼ 4.0 for 10 min) ratios from 1.5 0.1 and 2.3 0.4 mg
of BSA per milligram of microsphere were obtained.
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Figure 8. Effect of BSA coating: Ciprofloxacin release under gastric (a) and intestinal pH (b) from microspheres of alginate–gelatin crosslinked with
glutaraldheyde () and coated with BSA (*), and SEM images of coated microspheres with 140 (c) and 710 (d) magnification.
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Considering the high specific activity (units per milligram of
protein) of biological molecules like enzymes, the amount of
protein bound to microspheres surface is high enough to
deliver functional molecules activities.
Conclusions
Cip encapsulation in alginate–gelatin blend microspheres was
performed through a doubled crosslinked method by calcium
ion and glutaraldehyde in 1,2-propylene glycol–water solvent
mixtures. The developed matrix is showing a modified
surface structure for controlled release of the antibiotic.
Homogeneity of Cip dispersed into the matrix was confirmed
by FTIR spectra obtained by synchrotron light.
Characterization of the developed matrix was performed by
SEM and AFM images that showed a smooth surface of
microspheres when they were treated with glutaraldehyde.
Also, microspheres hardness and cohesivity were determined
by texturometric assays showing no changes between micro-
spheres synthesized in the absence or the presence of
glutaraldehyde without incubation at the assayed pHs.
However, significant stability associated to the both param-
eters in glutaraldheyde crosslinked microspheres at simulated
intestinal media (pH 7.4) incubated for two hours were found.
These results are suggesting that a thin film produced by
glutaraldehyde treatment on the microspheres surface was
responsible of the Cip release delay from the matrix. Also,
glutaraldehyde-treated microspheres in the presence of BSA
as a model protein showed a reduced kinetic Cip release from
the microspheres.
The deposition and quantities of BSA adsorbed into
the microsphere surfaces was confirmed by SEM and fluor-
escence microscopies and UV spectrophotometry analyses.
Antimicrobial activity of Cip release from the matrix was
kept almost constant over certain a period of time and tested
against P. aeruginosa showing high in vitro inhibition
efficiency. The alginate–gelatin matrix could be suitable for
oral delivery of Cip and treatment of recurrent infections
reducing the antibiotic toxicity at least in a half, which is an
advantage for long-term treatment and/or recurrent microbial
infections. Also, the matrix has the capability of bind proteins
onto surface, which is an attractive tool for attachment of
biological molecules with different functional properties,
such as antimicrobial peptides, enzymes, or others. The
microspheres blend composed by alginate–gelatin is provid-
ing a polifuntional ‘‘smart’’ matrix that can be tailored with
specific markers for diverse therapeutic purposes. In addition,
controlled release devices based on biopolymers is becoming
a new area for specifically targeted drug release for highly
toxic drugs, easily to scale up, with low cost and non-toxic
raw materials. Further experiments in cell cultures to
characterize the in vivo Cip release, matrix behavior and
toxicity are under way in our laboratory.
Figure 9. Optical and fluorescence microscopies of alginate/gelatin microspheres incubated with and without BSA conjugated with Alexa fluor
(Invitrogen Argentina, Buenos Aires, Argentina). Top: no treated; below: glutaraldehyde treated microsphere. Left: optical; right: fluorescence
microscopy (Exc¼ 497 nm).
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